Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,077 | -3,740 | -2,901 | -5,334 | -3,954 |
| Depreciation Amortization | 11 | 11 | 11 | 5 | 8 |
| Accounts receivable | -36 | -2 | 8 | -1 | 6 |
| Other Working Capital | -128 | 197 | 45 | 64 | 437 |
| Other Operating Activity | 3,346 | 1,815 | 1,625 | 3,233 | 1,788 |
| Operating Cash Flow | $-1,883 | $-1,719 | $-1,212 | $-2,033 | $-1,716 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -4 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,805 | 200 | 225 | N/A | N/A |
| Common Stock Issued | N/A | 1,581 | 929 | 2,056 | 1,444 |
| Other Financing Activity | 728 | 0 | 0 | 0 | -20 |
| Financing Cash Flow | $3,533 | $1,781 | $1,154 | $2,056 | $1,424 |
| Exchange Rate Effect | -41 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 155 | 92 | 151 | 129 | 425 |
| End Cash Position | 1,763 | 155 | 92 | 151 | 129 |
| Net Cash Flow | $1,609 | $62 | $-59 | $23 | $-297 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,883 | -1,719 | -1,212 | -2,033 | -1,716 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -4 |
| Free Cash Flow | -1,883 | -1,719 | -1,212 | -2,033 | -1,720 |